These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23668483)

  • 21. Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial.
    Barsheshet A; Goldenberg I; Moss AJ; Huang DT; Zareba W; McNitt S; Klein HU; Guetta V
    J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1237-42. PubMed ID: 21615813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?
    Schulz N; Püschel K; Turk EE
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):444-8. PubMed ID: 19168462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.
    Bhavnani SP; Pavuluri V; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):878-84. PubMed ID: 23614760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis.
    Korantzopoulos P; Liu T; Li L; Goudevenos JA; Li G
    Europace; 2009 Nov; 11(11):1469-75. PubMed ID: 19812050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
    Krahn AD; Lee DS; Birnie D; Healey JS; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):136-42. PubMed ID: 21325209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival after implantable cardioverter-defibrillator implantation in the elderly.
    Yung D; Birnie D; Dorian P; Healey JS; Simpson CS; Crystal E; Krahn AD; Khaykin Y; Cameron D; Chen Z; Lee DS
    Circulation; 2013 Jun; 127(24):2383-92. PubMed ID: 23775193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fragmented QRS and mortality risk in patients with left ventricular dysfunction.
    Cheema A; Khalid A; Wimmer A; Bartone C; Chow T; Spertus JA; Chan PS
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):339-44. PubMed ID: 20511537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality.
    Ousdigian KT; Borek PP; Koehler JL; Heywood JT; Ziegler PD; Wilkoff BL
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):370-6. PubMed ID: 24838004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical risk score to predict the time to first appropriate device therapy in recipients of implantable cardioverter defibrillators.
    Hreybe H; Saba S
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):385-9. PubMed ID: 17367358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
    Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization trends and clinical outcomes in patients implanted with a single- vs a dual-coil implantable cardioverter-defibrillator lead: Insights from the ALTITUDE Study.
    Hsu JC; Saxon LA; Jones PW; Wehrenberg S; Marcus GM
    Heart Rhythm; 2015 Aug; 12(8):1770-5. PubMed ID: 25916569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®.
    Russo AM; Wang Y; Al-Khatib SM; Curtis JP; Lampert R
    Pacing Clin Electrophysiol; 2013 Dec; 36(12):1522-31. PubMed ID: 23981009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep-disordered breathing in patients with implantable cardioverter-defibrillator.
    Grimm W; Apelt S; Timmesfeld N; Koehler U
    Europace; 2013 Apr; 15(4):515-22. PubMed ID: 23129543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The pacemaker and implantable cardioverter-defibrillator registry of the Italian Association Arrhythmology Cardiac Pacing and cardiac pacing - annual report 2013].
    Proclemer A; Zecchin M; D'Onofrio A; Botto GL; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D
    G Ital Cardiol (Rome); 2014 Nov; 15(11):638-50. PubMed ID: 25424143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.